Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study.
暂无分享,去创建一个
M. Alavi | P. Read | G. Dore | J. Amin | L. Degenhardt | C. Treloar | J. Grebely | A. Conway | H. Valerio | C. Henderson | M. Christmass | M. Montebello | D. Silk | Carolyn J. Murray
[1] M. Alavi,et al. Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study. , 2022, The International journal on drug policy.
[2] J. Ward,et al. Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis. , 2022, The lancet. Gastroenterology & hepatology.
[3] J. Grebely,et al. Concordance between self-reported and current hepatitis C virus infection status in a sample of people who inject drugs in Sydney and Canberra, Australia. , 2021, Drug and alcohol review.
[4] G. Dore,et al. Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the Clinic. , 2020, The Journal of infectious diseases.
[5] N. Terrault,et al. Gaps in Viral Hepatitis Awareness in the United States in a Population-based Study. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[6] J. Leung,et al. Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs , 2018, Addiction.
[7] F. Altice,et al. Hepatitis C virus status awareness and test results confirmation among people who inject drugs in Ukraine. , 2018, The International journal on drug policy.
[8] G. Dore,et al. Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay , 2018, The Journal of infectious diseases.
[9] G. Dore,et al. Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levels. , 2013, The Journal of infectious diseases.
[10] G. Dore,et al. Experience of hepatitis C testing among injecting drug users in Sydney, Australia , 2008, AIDS care.